STAA

Staar Surgical Co
Data: 2026-02-02
$18.04
Price
-4.64%
Change
$30.81
52W High
$13.5
52W Low

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Quick Stats
Feb 02, 2026

52.3

AI Score

HOLD

0.71

Volume Ratio

Feb 10, 2026

Next Earnings

8

+ve Days (30d)

20

-ve Days (30d)

STAA Stock Summary

Last updated Feb 02, 2026

STAA is currently trading at $18.04, positioned below its 200-day moving average of $22.63, suggesting bearish momentum. The stock has a 52-week range of $13.5 to $30.81.

Technical Analysis: The 50-day moving average stands at $23.31, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 23.23, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.062, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates STAA at 52.3/100 with a HOLD recommendation.

STAA (Staar Surgical Co) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 23.23
CMF (20) 0.062
ROC (10) -13.972
ADX (14) 44.229
Indicator Value
MACD (12,26,9) -1.39
AROONOSC (14) -100.0
WILLAMS %R (14) -99.036
MFI (14) 22.339
STAA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

STAA Price vs Max Options Open Interest
STAA Max Change In Options Open Interest

STAA Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

STAA Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

STAA Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

STAA Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Staar Surgical Co is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

STAA Moving Averages Analysis

STAA (Staar Surgical Co) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 19.39
20 20.69
30 21.72
50 23.31
100 24.95
200 22.63

STAA Fundamental Analysis

P/E (Forward) 49.7512
P/E (Trailing) --
Market Cap ($) 935.5 million
Earnings/Share ($) -1.96
Net Proft Margin (%) -0.4179
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.0133
EPS Estimate Next Year ($) 0.3683
WallStreet Target Price ($) 23.3611
Most Recent Quarter